Live Breaking News & Updates on Peiqing Qian

Stay updated with breaking news from Peiqing qian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ACTRIMS 2023: Most patients on Briumvi show no MS activity after 6 months | Briumvi led to no MS activity in 80% of patients in ULTIMATE trials

More than 80% of MS patients on Briumvi in the ULTIMATE trials had no signs of disease activity after the first six months, data show. ....

United States , San Diego , Enrique Alvarez , Peiqing Qian , Swedish Neuroscience Institute , University Of Colorado , Americas Committee For Treatment , Research In Multiple Sclerosis , Americas Committee , Multiple Sclerosis , Disease Activity With Ublituximab , Participants With Relapsing Multiple Sclerosis ,